Bipartisan AGs Reach $49 Million Settlement over Alleged Price-Fixing in Generic Drugs Market

Cozen O'Connor
Contact
LinkedIn
Facebook
X
Send
Embed

Cozen O'Connor

  • A bipartisan coalition of 50 states, D.C., and two territories reached settlements with Heritage Pharmaceuticals, Inc. and Apotex Corp. to resolve allegations of price fixing generic drugs in violation of the Sherman Act.
  • As part of complaints filed in 2017 and 2019, the AGs allege that the companies, along with other drug manufacturers and their executives, coordinated to inflate prices for multiple generic drugs used to treat a number of conditions, among other things.
  • Under the terms of the settlement agreement with Heritage, the company is required to pay $10 million to be used for restitution and costs. According to the AGs, Apotex is required to pay $39 million. Both companies must also cooperate in ongoing litigation against other companies.
  • We have previously reported on Mississippi AG Lynn Finch’s settlement with Teva Pharmaceuticals USA, Inc. to resolve similar claims.
Send Print Report

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations. Attorney Advertising.

© Cozen O'Connor

Written by:

Cozen O'Connor
Cozen O'Connor
Contact
more
less

PUBLISH YOUR CONTENT ON JD SUPRA NOW

  • Increased visibility
  • Actionable analytics
  • Ongoing guidance

Cozen O'Connor on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign Up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide